Drug
Enoxaparin sodium clinical trials
Also written Lovenox and Clexane.
A product of Enoxaparin; its studies count on that page too.
- studies test it
- 35
- open now
- 5
- in phase 3
- 7
- first study started
- 2002
Keep track of what changes. Save the enoxaparin sodium studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
35 studies that test it; most in 2020 (5)
| Year | Studies |
|---|---|
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 5
- Phase 3
- 7
- Phase 4
- 14
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 21
Sanofi (6) · Chemi S.p.A. (2) · University of Monastir (2) · Lahore General Hospital (1) · PT Bio Farma (1) · Columbia University (1) · Johns Hopkins All Children's Hospital (1) · Venus Remedies Limited (1)
Often tested with
Tested in the same studies.
Aspirin (3) · Heparin (2) · Rivaroxaban (2) · Dalteparin (1) · Tinzaparin (1) · Apixaban (1) · Dabigatran (1) · Fondaparinux (1)
Studies
Open first, then newest update. How each study uses enoxaparin sodium is read from its arms, and is right about nine times in ten.
Testing it · 35
- Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot ProjectRecruitingPhase 2Endeavor HealthNCT06004674Written as Lovenox 40mg
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Enoxaparin Sodium
- Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)RecruitingPhase 4University of California, IrvineNCT04861103Written as Lovenox
- Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)RecruitingPhase 4Oregon Health and Science UniversityNCT02342444Written as Enoxaparin Sodium Injection 30 mg BID
- Lovenox With Aspirin in Thawed Blastocyst TransferRecruitingPhase 4Fertility Center of Las VegasNCT06133803Written as Lovenox
- Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative VitreoretinopathyActive, not recruitingNot applicableLahore General HospitalNCT07787377Written as Enoxaparin Sodium
- Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS PatientsCompletedPhase 4PT Bio FarmaNCT06114641Written as Enoxaparin sodium injection
- Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19CompletedPhase 4Columbia UniversityNCT04367831Written as Enoxaparin Prophylactic Dose
- COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) TrialCompletedPhase 2Johns Hopkins All Children's HospitalNCT04354155Written as Enoxaparin Prefilled Syringe [Lovenox]
- Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human SubjectsCompletedPhase 1Venus Remedies LimitedNCT05265676Written as Enoxaparin Sodium (Venus Remedies Limited)
- A Different Approach to Preventing ThrombosisCompletedPhase 3University of Maryland, BaltimoreNCT02774265Written as VTE prophylaxis with Enoxaparin 30mg BID
- Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNot applicableLehigh Valley HospitalNCT00521885Written as Lovenox 40mg SC Daily
- A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting ConditionsCompletedPhase 1Chemi S.p.A.NCT02081950Written as Enoxaparin sodium
- Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.CompletedPhase 1Chemi S.p.A.NCT02232802Written as Enoxaparin Sodium
- Enoxaparin Bioequivalence Study in Acute Coronary Syndrome PatientsCompletedPhase 1University of MonastirNCT04552067Written as Lovenox
- Concentration-effect Relationship of Enoxaparin for Thromboembolic PreventionWithdrawnPhase 4Centre Hospitalier Universitaire de Saint EtienneNCT04520620Written as Lovenox 40 MG in 0.4 mL Prefilled Syringe
- Enoxamed Study in the Treatment of Acute Coronary SyndromesCompletedPhase 1University of MonastirNCT02152423Written as LOVENOX
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs RivaroxabanStatus unknownPhase 4Florida Orthopaedic InstituteNCT04169269Written as Enoxaparin 40 milligram/0.4 milliliter Injectable Syringe 0.4 milliliters
- Timing of VTE Prophylaxis in TBIWithdrawnPhase 4Loyola UniversityNCT03081169Written as Enoxaparin Sodium 150 MG/ML Prefilled Syringe
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery PatientsCompletedPhase 1University of UtahNCT02687204Written as Twice daily enoxaparin prophylaxis
See all 35 studies that test enoxaparin sodium →
Given in every arm · 5 — enoxaparin sodium is usual care beside what is tested
- Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)TerminatedPhase 4Weill Medical College of Cornell UniversityNCT04406389Written as Enoxaparin sodium
- A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet AlfaCompletedPhase 1Portola PharmaceuticalsNCT03083704Written as Enoxaparin sodium
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet TransplantationCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00789308Written as Klexane® (Enoxaparinsodium)
- Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®CompletedPhase 1/2Indonesia UniversityNCT04402762Written as Enoxaparin Prefilled Syringe [Lovenox]
- Warfarin Initiation in Mechanical Mitral Valve Replacement PatientsCompletedPhase 4Sarah Sabry HashemNCT04235569Written as Enoxaparin Sodium 100 MG/ML Prefilled Syringe
As the comparator · 21 — what is tested is compared with enoxaparin sodium
- Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord InjuryRecruitingNot applicableLoewenstein HospitalNCT05484557Written as Enoxaparin Sodium
- Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee ArthroplastyRecruitingPhase 2Livzon Pharmaceutical Group Inc.NCT06963320Written as Enoxaparin Sodium Injection
- A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedPhase 3Beijing Suncadia Pharmaceuticals Co., LtdNCT06825416Written as Enoxaparin sodium injection
- Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to EnoxaparinCompletedPhase 3Avexima Diol LLCNCT07124819Written as Sodium enoxaparin
- A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer SurgeryCompletedPhase 2Beijing Suncadia Pharmaceuticals Co., LtdNCT06220123Written as Enoxaparin Sodium Injection; Rivaroxaban Tablets
- SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedPhase 2Beijing Suncadia Pharmaceuticals Co., LtdNCT05752461Written as Enoxaparin sodium injection
- Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 PatientsCompletedNot applicableUniversity Magna GraeciaNCT05334654Written as Enoxaparin Sodium
- Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19CompletedPhase 3PharmaDiall Ltd.NCT05185804Written as Clexane
- Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)TerminatedPhase 1/2GlycoMimetics IncorporatedNCT02744833Written as Enoxaparin Sodium (Lovenox®)
- A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT01181167Written as enoxaparin sodium
- Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT01181141Written as Enoxaparin sodium 20mg
- A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT01181102Written as enoxaparin sodium
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedPhase 2Daiichi Sankyo Co., Ltd.NCT01203098Written as Enoxaparin sodium 20 mg (=2000IU)
- Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult SubjectsCompletedPhase 1GlycoMimetics IncorporatedNCT02271113Written as Enoxaparin Sodium (Lovenox®)
- Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVTCompletedPhase 3Berlin-Chemie AG Menarini GroupNCT01880216Written as Enoxaparin sodium
- Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryCompletedPhase 3Bristol-Myers SquibbNCT00371683Written as Enoxaparin + Placebo
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedPhase 3SanofiNCT00679588Written as Enoxaparin sodium
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture SurgeryCompletedPhase 3SanofiNCT00721760Written as Enoxaparin sodium
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement SurgeryCompletedPhase 3SanofiNCT00697099Written as Enoxaparin sodium
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted MobilityTerminatedPhase 3SanofiNCT00714597Written as Enoxaparin sodium
Showing 20 of 21.
Codes
What other systems call enoxaparin sodium · ClinicalTrials.gg INT001461
- MeSH (NLM) C000711671enoxaparin sodiumConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 8NZ41MIK1OENOXAPARIN SODIUMConfirmed FDA, NLM, Wikidata
- RxNorm 221095Confirmed FDA, Wikidata
- Wikidata Q416516enoxaparin sodiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75769Enoxaparin SodiumConfirmed FDA, Wikidata
- DrugBank DBSALT002813One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000711671 | enoxaparin sodium | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 8NZ41MIK1O | ENOXAPARIN SODIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 221095 | — | Confirmed FDA, Wikidata |
| Wikidata | Q416516 | enoxaparin sodium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75769 | Enoxaparin Sodium | Confirmed FDA, Wikidata |
| DrugBank | DBSALT002813 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.